1. Sphingolipids—Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases
2. (a) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750–770;
3. Reviews: (a) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750–770; (b) Carbohydrate Mimics; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, 1998; (c) Nash, R. J.; Watson, A. A.; Asano, N. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Pergamon: Tarrytown, New York, 1996; pp. 345–376.
4. (c) Nash, R. J.; Watson, A. A.; Asano, N. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Pergamon: Tarrytown, New York, 1996; pp. 345–376.
5. (a) Review: Hauser, F. M.; Ellenberger, S. R. Chem. Rev. 1986, 86, 35–67;